| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 1.85 | 0.00 (0.00%) | 0.80 - 3.10 | 0.0 |
Market data as of 12:00AM 05/16/13. Quotes are delayed by at least 15 min.
Hadasit Bio-Holdings CEO Letter to Shareholders
04/09/2013 9:00 AM ET
Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA
04/04/2013 9:11 AM ET